" class="no-js "lang="en-US"> Fundraising Archives - Page 3 of 37 - Medtech Alert
Wednesday, March 29, 2023

Sort by:


Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Oricell Closes $45M Series B1 Financing to Expand Development of Key Products

Oricell Therapeutics, a China-based innovative pharmaceutical company committed to the development of tumor cellular immunotherapeutics, […]

Eluminex Biosciences Closes $40+ Million Series B Financing

Eluminex Biosciences has officially announced the closing of a Series B financing of over $40 […]

Genascence Receives $11.6 Million Award From California Institute for Regenerative Medicine to Help Advance its Lead Gene Therapy Program in Knee Osteoarthritis

Genascence Corporation, a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene […]

Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders

Hemab Therapeutics, a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding […]

Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines

Aera Therapeutics announced its launch today with a vision to harness its proprietary delivery platform […]

Previa Medical Raises €2.1 Million for AI Solution to Prevent Sepsis

Previa Medical, a deeptech start-up specialized in developing predictive medical devices for alerting healthcare providers […]

Morphoceuticals Raises $8 million to Advance Electroceutical Approach to Regenerative Medicine

Morphoceuticals, a biotechnology company, announced it closed an $8 million Seed-2 funding round led by […]

Ryne Biotechnology Awarded $4 Million from the California Institute for Regenerative Medicine

Ryne Biotechnology, a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and […]

BiPER Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-class Small Molecules to Treat Gastrointestinal Cancers

BiPER Therapeutics, a preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to treat […]

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million […]

  1. PharmaVentures Establishes an Office in Seoul to Enhance Access for South Korean Biotechs Read more
  2. Genialis Raises $13M in Financing to Build Clinical Biomarkers that Predict Patient Response Read more
  3. Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment Read more
  4. Lantern Pharma Announces First Patient Dosed in Study for LP-300 in Never Smokers with Advanced Non-Small Cell Lung Cancer Read more
  5. Transcenta’s Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer Read more